SCHEMBL10157157

SCHEMBL10157157

CSc1nc(Nc2cccc(S(C)(=O)=O)c2)cc(=O)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 1/20 0.50
▸ TNNI3K Q59H18 3/20 0.47
▸ POLB P06746 3/20 0.46
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ GFER P55789 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ STK10 O94804 2/20 0.41
▸ SLK Q9H2G2 2/20 0.41
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ EPHB4 P54760 2/20 0.40
▸ CCNB2 O95067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10156964 0.88 TNNI3K (0.55) TNNI3KPOLBEGFR
SCHEMBL10157834 0.88 POLB (0.44) ROCK1TNNI3KPOLBMAPTMEN1
SCHEMBL10156028 0.86 POLB (0.43) ROCK1TNNI3KPOLBMAPTMEN1
SCHEMBL10156550 0.86 POLB (0.48) TNNI3KPOLBMAPTMEN1ALDH1A1
SCHEMBL282919 0.74 EML4 (0.45) ROCK1TNNI3KMEN1KMT2AGFER
SCHEMBL10127137 0.74 GFER (0.43) ROCK1TNNI3KMEN1ALDH1A1KMT2A
SCHEMBL10156777 0.72 POLB (0.42) POLBMEN1KMT2AGFERRXFP1
SCHEMBL8160226 0.72 POLB (0.48) POLBMAPTMEN1ALDH1A1KMT2A
SCHEMBL10156985 0.71 PIK3CA (0.43) POLBMAPTKDM4ELMNASMN1; SMN2
SCHEMBL10156704 0.70 ROCK1 (0.45) ROCK1POLBMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ROCK1 1597/4885TNNI3K 1317/4885POLB 4590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback